An early preclinical PET imaging study used a 64Cu-DOTA-anti-murine CTLA-4 IgG2a antibody to visualize T cells in a murine CT26 colon cancer model in BALB/c mice as to evaluate the prospect of imaging CTLA-4 134. Here, CTLA4 is linked to malignant colon neoplasm.